Venrock Healthcare Capital Partners III, L.P. 13D/13G Filings for enGene Holdings Inc. (ENGN)

Venrock Healthcare Capital Partners III, L.P. 13D and 13G filings for enGene Holdings Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-02-17
6:09 pm
Sale
2025-12-3113GENGENE HLDGS INC
ENGN
Venrock Healthcare Capital Partners III, L.P.4,771,414
7.100%
-275,000decrease
(-5.45%)
Filing
2025-02-14
6:15 pm
Purchase
2024-12-3113GENGENE HLDGS INC
ENGN
Venrock Healthcare Capital Partners III, L.P.5,046,414
9.900%
1,480,573increase
(+41.52%)
Filing
2024-11-14
5:48 pm
Purchase
2024-09-3013GENGENE HLDGS INC
ENGN
Venrock Healthcare Capital Partners III, L.P.3,565,841
8.100%
1,000,000increase
(+38.97%)
Filing
2024-02-26
4:15 pm
Purchase
2024-02-1613GENGENE HLDGS INC
ENGN
Venrock Healthcare Capital Partners III, L.P.2,565,841
5.900%
2,565,841increase
(New Position)
Filing